ClinicalTrials.gg
CompletedNCT05708768Updated Aug 8, 2025

Digital, Innovative, Sustainable, and Knowledge-based Acute Municipal Healthcare Services Illness and Trauma

An observational study in Multiple Chronic Conditions and Acute Disease, sponsored by Ostfold University College. Completed at 1 site in Norway. Per ClinicalTrials.gov, last updated 2025-08-08.

Sponsored by Ostfold University College · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
1,000
Sex
All
01

Study summary

Through introducing physicians in front in the medical assessment and decision-making processes in acute and sub-acute illness in the municipalities, as well as including machine learning in analyzing prospective and retrospective data, the project will develop and implement innovative and knowledge-based digital diagnostic tools and decision-making support systems to be used in the municipalities. As such, the project will contribute to early identification of severe illness, prevent deterioration of disease, and facilitate early medical intervention.

Read the detailed description

The overall objective of the project is to determine if and how innovative digital decision-making tools based on artificial intelligence (AI) can help to develop more accessible, efficient, cost-effective, and sustainable municipal healthcare services. More specifically, the project aims are:

  • to explore different outcomes of a municipal rapid response car manned with dedicated physicians
  • to compare outcomes from Norwegian and Swedish out-of-hospital EMS in acute illness
  • to explore how decision-making tools based on AI can be used to optimize dispatch
  • to explore how decision-making tools based on AI can assist dispatched personnel and in prehospital care
  • to determine the quality and efficacy of the different systems explored through cost-analyses and exploration of stakeholders' experiences with the decision-making tools
02

Conditions studied

  • Multiple Chronic Conditions
  • Acute Disease
03

In context

Multiple Chronic Conditions

89 studies on the registry are indexed under Multiple Chronic Conditions; 16 are open to participants now.

This study's enrollment of 1,000 is above the median of 160 across 16 observational studies indexed under Multiple Chronic Conditions.

Browse Multiple Chronic Conditions studies →

Lead sponsor

Ostfold University College is the lead sponsor of 15 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients recieving services from the physician manned rapid response car will be included.

Eligibility criteria

Inclusion Criteria:all patients receiving services from the physician manned rapid response car -

Exclusion Criteria:none

-

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
1,000 participants (actual)
Patient registry
No

Groups and cohorts

  • Acutely ill persons in the municipality

    Patients recieving services from a rapid response vehicle manned with dedicated physicians from the municipality

    Other: Receiving physician manned rapid response car services

Interventions

  • OtherReceiving physician manned rapid response car services

    All patients receiving services from the physician manned rapid response car will be included

06

What researchers measure

Primary outcomes

  1. At location

    Patients treated at location

    Time frame: 2 hours

Secondary outcomes

  1. Transported

    Patients being transported for further diagnostics

    Time frame: 2 hours

Other outcomes

  1. Institutionalized

    Patients being institutionalized

    Time frame: 12 hours

07

Study locations

1 site
  • Fredrikstad Casualty
    Fredrikstad, Akershus 1671, Norway
08

References and documents

Individual participant data

Plan to share: Yes — The goal is to publish anonymized datasets. ØUC is an institutional member of the DataverseNO community in Norway, and the DataverseNO-based repository ØUC Open Research Data, which is a generic repository of high quality, is suitable for this endeavor. A part of the data generated by this research project consists of qualitative interviews. In case these data cannot be anonymized, open publication of data will be refrained and rather opt for making metadata available. Datasets and metadata will be published in connection with open access publication of research articles.

Supporting information: Study protocol, Clinical study report

Time frame: After all publication

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05708768
Lead sponsor
Ostfold University College
Collaborators
Oslo University Hospital, Ostfold Hospital Trust, OsloMet
Responsible party
Sponsor
First posted
Feb 1, 2023
Start date
Oct 1, 2022
Primary completion
Jan 1, 2025
Completion
Jan 1, 2025
Last update
Aug 8, 2025

Study contacts

Randi M Sommerfelt, PhD
study chair · Østfold University College

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion